RT Journal Article
SR Electronic
T1 Misalignment between circadian preference and accelerometer-derived actual sleep-wake cycle is associated with increased risk of cardiometabolic diseases: a prospective cohort study in UK Biobank
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2024.06.28.24309628
DO 10.1101/2024.06.28.24309628
A1 Chen, Yue
A1 Geng, Tingting
A1 Xu, Xinming
A1 Zhang, Zhicheng
A1 Huang, Lili
A1 Dong, Haiyang
A1 Yu, Huan
A1 Gao, Xiang
A1 Sun, Liang
YR 2024
UL http://medrxiv.org/content/early/2024/06/28/2024.06.28.24309628.abstract
AB Background Evidence has linked several circadian disruption indicators, such as social jetlag and shift work, to adverse health outcomes, however, associations of misalignment between circadian preference and actual sleep-wake cycle with cardiometabolic diseases (CMDs) remains unclear. We aimed to prospectively investigate the associations of the circadian misalignment with CMDs including type 2 diabetes (T2D), chronic heart diseases (CHD), and stroke, and to uncover potential mechanisms linking circadian misalignment and CMDs.Methods A total of 60,965 participants from the UK Biobank study without baseline CMDs and followed-up for an average of 7.9 years were included in the current analysis. Circadian misalignment was defined as discrepancies between self-reported chronotype and accelerometer-derived midpoint of sleep to detect its association with CMDs. Incident CMDs were derived from primary care, hospital inpatient, death registry, and self-reported source of data. Cox proportional hazards regression models were used to compute the hazard ratio (HR) and confidence intervals (CIs) on the association between circadian misalignment (quintiles of residuals of midsleep on chronotype) and incident CMDs.Results U-shaped associations were found of the circadian misalignment with incident T2D and CHD after adjusting the potential confounders. Compared to individuals with aligned midsleep and circadian preferences (Q3), those with advanced and delayed circadian misalignment had higher risks of T2D [HR (95%CI) 1.22 (1.03, 1.45) in Q1 and 1.39 (1.18, 1.62) in Q5]. However, only delayed circadian misalignment was significantly associated with an increased risk of CHD [HR (95%CI) 1.15 (1.01, 1.31) in Q4 and 1.16 (1.02, 1.33) in Q5]. Liver function, lipid and glucose metabolism, and inflammatory markers partially explained the observed circadian misalignment and CMDs association (mediation proportion 12.3-44.6% for T2D, 8.8-20.5% for CHD). Moreover, the association between delayed circadian misalignment and CMDs was more prominent in women (for T2D, Pinteraction=0.03) and in younger adults (for CHD, Pinteraction=0.02) compared to their counterparts. Additionally, early chronotype [HR (95%CI): 1.19 (1.06, 1.34)] rather than late chronotype was associated with an increased risk of incident T2D.Conclusion Both advanced and delayed circadian misalignment were associated with increased risks of CMDs, suggesting potential benefits of aligning actual sleep-wake cycles with individual circadian preferences.What is known?Cardiometabolic diseases such as type 2 diabetes, coronary heart disease, and cerebrovascular diseases have become major concerns in global public health over recent decades.Evidence has linked several circadian disruption indicators to adverse health outcomes: People living with late chronotype (circadian preference), late sleep timing, long social jetlag (the difference between midsleep on work-free days and work days), and shift work were prone to introduce circadian disruptions and had higher risks of cardiometabolic diseases.Little is known about whether and how the misalignment between circadian preference and actual sleep-wake cycle is associated with cardiometabolic diseases, particularly in large prospective cohort studies.What New Information Does This Article Contribute?This is the first study to propose a new metrics (misalignment between circadian preference and actual sleep-wake cycle) to shed some lights on quantifying human circadian disruption in general population of differed work schedule and in population with less disrupted circadian rhythm.Both advanced and delayed sleep-wake cycle comparing to individual circadian preference were associated with increased risks of cardiometabolic diseases. Population may benefit from keeping an actual sleep-wake cycle in accordance with their circadian preference.Early chronotype rather than late chronotype were found to associate with an increased risk of incident T2D, independent of actual sleep-wake cycle.Age and sex modified the associations between circadian misalignment and cardiometabolic diseases, while liver function, lipid and glucose metabolism, and inflammatory markers partially mediated the associations.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was funded by the Major Project of the Ministry of Science and Technology of China (2023YFC2506704) and the Startup grant from Fudan University (JIF201068Y and IDF201026Y).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The UK Biobank was granted ethical approval from the North West Multi-center Research Ethical Committee (reference # 11/NW/0382) and research is performed in accordance with the Declaration of Helsinki.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesThis research has been conducted using the UK Biobank Resource under Application Number 96083. Data from UK Biobank is accessible to eligible researchers via applying. http://www.ukbiobank.ac.uk